BMI | Odds Ratio (OR) | p | 95% Confidence Interval | |
---|---|---|---|---|
Overweight | ||||
Treatment (TR) (control) | 1.00 | |||
Treatment (TR) (intervention) | 0.45 | 0.243 | 0.12 | 1.71 |
Stage (baseline) | 1.00 | |||
Stage (final) | 0.93 | 0.413 | 0.77 | 1.11 |
Interaction TR*stage | 0.89 | 0.225 | 0.73 | 1.11 |
Sex(female) | 0.8 | 0.135 | 0.6 | 1.1 |
Age | 0.82 | 0.513 | 0.78 | 1.13 |
SEI (Low) | 1.00 | |||
SEI(Medium) | 1.51 | 0.011 | 1.10 | 2.07 |
SEI(High) | 1.82 | < 0.001 | 1.30 | 2.56 |
Carbohydrates | 0.99 | 0.259 | 0.99 | 1.00 |
Lipids | 1.05 | 0.229 | 1.01 | 1.01 |
PA (moderate actives) | 1.01 | 0.573 | 0.79 | 1.52 |
PA (actives) | 1.03 | 0.843 | 0.79 | 1.32 |
Eating notes | 1.02 | 0.551 | 0.94 | 1.11 |
PA notes | 0.93 | 0.209 | 0.82 | 1.04 |
PA auto-efficacy notes | 1.15 | < 0.001 | 1.07 | 1.24 |
Eating auto-efficacy notes | 0.92 | 0.099 | 0.83 | 1.02 |
Interaction TR* Carbohydrates | 0.99 | 0.060 | 0.99 | 1.00 |
Interaction TR* PA notes | 1.16 | 0.090 | 0.98 | 1.37 |
Obesity | ||||
Treatment (TR) (control) | 1.00 | |||
Treatment (TR) (intervention) | 0.34 | 0.251 | 0.06 | 2.13 |
Stage(baseline) | 1.00 | |||
Stage(final) | 1.29 | 0.065 | 0.98 | 1.70 |
Interaction TR*stage | 0.68 | 0.010 | 0.51 | 0.91 |
Sex(female) | 0.56 | 0.002 | 0.39 | 0.80 |
Age | 0.89 | 0.399 | 0.68 | 1.17 |
SEI (Low) | 1.00 | |||
SEI (Medium) | 168 | 0.041 | 1.02 | 2.75 |
SEI(High) | 2.99 | < 0.001 | 1.83 | 4.91 |
Carbohydrates | 1.00 | 0.705 | 0.99 | 1.00 |
Lipids | 0.99 | 0.270 | 0.98 | 1.00 |
PA (moderate actives) | 0.83 | 0.436 | 0.51 | 1.34 |
PA (actives) | 1.06 | 0.747 | 0.73 | 1.55 |
Eating notes | 1.07 | 0.237 | 0.95 | 1.21 |
PA notes | 0.87 | 0.146 | 0.73 | 1.05 |
PA auto-efficacy notes | 1.12 | 0.042 | 1.00 | 1.24 |
Eating auto-efficacy notes | 0.90 | 0.130 | 0.79 | 1.03 |
Interaction TR* Carbohydrates | 0.99 | 0.200 | 0.99 | 1.00 |
Interaction TR* PA notes | 1.29 | 0.044 | 1.01 | 1.59 |